Last reviewed · How we verify
Cancer
Approved treatments
- Fludeoxyglucose F-18 · Downstate Clincl
Fludeoxyglucose F-18 is a radioactive sugar molecule that accumulates in cells with high metabolic activity, allowing for visualization of cancer and other conditions. - Fludeoxyglucose F-18 · 3D Imaging Drug
Fludeoxyglucose F-18 is a radioactive molecule that accumulates in areas of high metabolic activity, allowing for imaging of various conditions.
Pipeline
- encorafenib + binimetinib · Pfizer Inc. — discontinued
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Cancer patent landscape — cliff calendar, originator estates, attackable patents
- Cancer treatment landscape brief
- Cancer treatment updates RSS
Frequently asked questions about Cancer
What drugs treat Cancer?
Tracked treatments include Fludeoxyglucose F-18.
What is the treatment for Cancer?
Standard treatment for Cancer includes Fludeoxyglucose F-18. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Cancer?
1 pipeline drugs tracked. Top candidates: encorafenib + binimetinib.
Related
- Treatment landscape: Cancer patent cliff · Cancer CI report
- Treatment: Fludeoxyglucose F-18 · Downstate Clincl
- Treatment: Fludeoxyglucose F-18 · 3D Imaging Drug
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing